MACPX
Price
$26.20
Change
+$0.12 (+0.46%)
Updated
Dec 24 closing price
RLBCX
Price
$34.57
Change
+$0.23 (+0.67%)
Updated
Dec 24 closing price
Ad is loading...

MACPX vs RLBCX

Header iconMACPX vs RLBCX Comparison
Open Charts MACPX vs RLBCXBanner chart's image
BlackRock Sustainable Balanced Instl
Price$26.20
Change+$0.12 (+0.46%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R3
Price$34.57
Change+$0.23 (+0.67%)
VolumeN/A
CapitalizationN/A
MACPX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MACPX vs. RLBCX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MACPX is a StrongBuy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 238B vs. MACPX (1.62B). MACPX pays higher dividends than RLBCX: MACPX (2.84) vs RLBCX (1.98). MACPX was incepted earlier than RLBCX: MACPX (51 years) vs RLBCX (23 years). RLBCX is a more actively managed with annual turnover of: 171.00 vs. MACPX (152.00). RLBCX has a lower initial minimum investment than MACPX: RLBCX (250) vs MACPX (2000000). RLBCX annual gain was more profitable for investors over the last year : 11.06 vs. MACPX (10.28). RLBCX return over 5 years is better than : 29.35 vs. MACPX (21.96).
MACPXRLBCXMACPX / RLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence51 years23 years-
Gain YTD9.69810.60991%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B238B1%
Annual Yield % from dividends2.841.98144%
Returns for 1 year10.2811.0693%
Returns for 3 years5.499.0361%
Returns for 5 years21.9629.3575%
Returns for 10 years27.7250.4455%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWH0.770.02
+3.11%
Aspira Women's Health
FWRG19.280.40
+2.12%
First Watch Restaurant Group
WAB194.162.71
+1.42%
Wabtec
TXG14.67-0.06
-0.41%
10x Genomics
LXRX0.76-0.07
-8.37%
Lexicon Pharmaceuticals